Description

Furo[2,3-B]Pyridine-5-Carboxamide, 2-Bromo-n-[(4-Chlorophenyl)Methyl]-4,7-Dihydro-7-Methyl-4-Oxo- is a high-purity, heterocyclic organic compound featuring a fused furan and pyridine core with bromo and chlorophenyl substituents. This complex molecular architecture makes it a valuable and versatile pharmaceutical intermediate for the research and development of novel active ingredients. It is primarily sought by pharmaceutical R&D laboratories and fine chemical manufacturers engaged in the synthesis of advanced therapeutic agents.

Application

• Pharmaceutical Intermediate: Serves as a critical building block in the synthesis of novel drug candidates, particularly in medicinal chemistry research.
• Active Pharmaceutical Ingredient (API) Development: Used in the research and process development stages for creating new APIs with potential therapeutic applications.
• Biochemical Research: Employed as a standard or reagent in biochemical assays and pharmacological studies to investigate biological pathways.
• Organic Synthesis: Acts as a key precursor for constructing more complex heterocyclic compounds in academic and industrial research settings.
• Contract Research & Manufacturing (CRO/CMO): Supplied to organizations specializing in custom synthesis and scale-up services for the life sciences industry.

Basic Information

Product Name	Furo[2,3-B]Pyridine-5-Carboxamide, 2-Bromo-n-[(4-Chlorophenyl)Methyl]-4,7-Dihydro-7-Methyl-4-Oxo-
CAS No.	562101-75-1
Molecular Formula	C₁₆H₁₄BrClN₂O₂
Molecular Weight	381.65 g/mol
Synonyms	2-Bromo-N-[(4-chlorophenyl)methyl]-4,7-dihydro-7-methyl-4-oxofuro[2,3-b]pyridine-5-carboxamide; 2-Bromo-N-[(4-chlorophenyl)methyl]-7-methyl-4-oxo-4,7-dihydrofuro[2,3-b]pyridine-5-carboxamide; Furo[2,3-b]pyridine-5-carboxamide, 2-bromo-N-[(4-chlorophenyl)methyl]-4,7-dihydro-7-methyl-4-oxo-; 562101-75-1; AKOS005258212; CS-W009756; FT-0772135; NS00023823
EINECS	Contact for details

Quality Control

Our Furo[2,3-B]Pyridine-5-Carboxamide derivative is manufactured under strict quality management systems. Every batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation, to ensure it meets the high standards required for pharmaceutical research. A comprehensive Certificate of Analysis (COA) detailing purity, assay, and impurity profiles is provided with each shipment to guarantee traceability and consistency for your critical R&D applications.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (typically 15-25°C). This compound should be handled as a moisture-sensitive material. Keep away from incompatible substances.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 97.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Single Unknown Impurity (HPLC)	≤ 1.0%
Total Impurities (HPLC)	≤ 3.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.